sexual function during breastfeeding. Unspecified sexual dysfunction, not caused by organic disorder or disease
Conditions
Interventions
Intervention 1: Intervention group: Aromatherapy with 5%essential oils of Lavender, Foeniculum vulgare, Geranium, orange and rose are placed on skin as follows: 2-3 drops, three times a day for 40 day
Treatment - Other
Placebo
Intervention group: Aromatherapy with 5%essential oils of Lavender, Foeniculum vulgare, Geranium, orange and rose are placed on skin as follows: 2-3 drops, three times a day for 40 days.
Control group: The use of placebo (propylene glycol as an inert material and colored aroma) as follows: 2-3 drops, three times a day for 40 days will be placed on the skin to be absorbed.
Sponsors
Research Deputy of Nursing and Midwifery Faculty of Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
15 Years to 48 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1.Having family health records in Shaheidan Ebrahimi public health center; 2- Being able to complete the questionnaire; 3- Being married and living with her husband; 4- Using an effective contraception method; 5- Breastfeed women in 3-6 months after childbirth; 6- Lack of chronic disease; 7- Not currently taking drugs that may affect on sexual response (anti-hypertension, Thiazide diuretics, anti-depression, anti-histamines, Barbiturates, narcotics, diazepines, amphetamines, cocaine); 8- No severe emotional stress in past six months; 9- No olfactory disorder and the other disorders related to nose. Exclusion criteria: 1- No interest to participate; 2- occurrence drug side effects and allergy to essential oils during the study; 3- occurrence severe emotional stress such as death of close family or baby; 4- Getting pregnant during the study; 5- occurrence psychological complications or severe disease during the study; 6- Living away from husband.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sexual function. Timepoint: Before intervention, 40 days after intervention. Method of measurement: Female Sexual Function Index (FSFI) that will be self-administered and will be put into a sealed box. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAhdieh Maleki
Faculty of Nursing and Midwifery, Tabriz Univercity of Medical Sciences
Outcome results
None listed